Influence of Adiposity and Other Factors on the Gut Microbiota Composition
Red and White Meat Intake in Relation to Gut Flora in Obese and Non-Obese Arab Females
1 other identifier
observational
92
1 country
1
Brief Summary
People who are overweight are getting more and more common in every region of the world. However, despite significant progress being made in the treatment options available for overweight, the worldwide incidence of overweight has not gone down, and the challenge of overweight has become a worrisome phenomenon of our times. Additionally, the process that underlie this illness and the etiological variables are not fully comprehended. As a result, it is absolutely necessary to determine the factors that contribute to obesity and define the responsibilities that each play. Researchers have devoted a significant portion of the better part of the last decade to studying the microbiota of the gut to determine whether or not it may play a factor in the development of obesity. Across spite of this, there is a paucity of accessible epidemiological data in Saudi Arabia. In addition, the relationship between the composition of the "gut microbiota" and obesity indices in youthful women of reproductive age is little understood. In view of this, we decided to conduct a case study utilizing whole-genome shotgun sequencing to compare the gut microbiota of obese women from Saudi Arabia with that of healthy control participants. Our findings shed light on the significance of the gut microbiota in obesity and provide useful insight into the creation of a method for the therapy of obesity by means of microbiota transfer of fecal, antibiotics, probiotics, and prebiotics. In addition, these data reveal prospective targets for guiding the selection of probiotic strains for the needed gut microbiota regulation in the obesity therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedFirst Submitted
Initial submission to the registry
December 14, 2022
CompletedFirst Posted
Study publicly available on registry
December 23, 2022
CompletedDecember 23, 2022
December 1, 2022
1.2 years
December 14, 2022
December 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlations between gut flora by type of meat intake in total participants
cross-sectional analysis
Baseline
Study Arms (2)
Normal weight
Body mass index (BMI) between 18.50 and 24.99 kilograms per square meter
Obese
Body mass index (BMI) of more than 30 kilograms per square meter
Interventions
obese \[(BMI ≥30 kg/m2), (n=44)\], and non-obese \[(BMI= 18.50-24.99 kg/m2), (n=48)\].
Eligibility Criteria
92 Saudi female students aged (18 to 25 years), classified into; obese \[(BMI ≥30 kg/m2), (n=44)\], and non-obese \[(BMI= 18.50-24.99 kg/m2), (n=48)\].
You may qualify if:
- Females
- to 25 years of age
- Normal weight: body mass index (BMI): 18.00-24.99 kg/m2
- Obese: BMI ≥ 30 kg/m2
You may not qualify if:
- Less than 18 years old or above 25 years
- Overweight (BMI); 25.0-29.9 kg/m2)
- Pregnant
- Following specific diets (e.g., calorie-restricted diets)
- Reported the presence of gastrointestinal diseases in the past eight weeks
- Endocrine or oncological disease history, psychiatric disorders, anorexia, other medical conditions
- Usage of multi-vitamins or vitamin B12 and antibiotics in the past 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ghadeer Aljuraiban
Riyadh, 12444, Saudi Arabia
Biospecimen
the DNA was extracted from 0.25 g frozen stool aliquots by the QIAGEN PowerFecal DNA Kit (Catalogue: 12830-50). The purity of the isolated DNA (260/280 ratio) and concentration was measured utilizing a NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA).
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ghadeer Aljuraiban, PhD
KSU
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 14, 2022
First Posted
December 23, 2022
Study Start
January 1, 2019
Primary Completion
March 1, 2020
Study Completion
December 1, 2021
Last Updated
December 23, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share
Collaborations are welcomed upon contacting the corresponding author